Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system

Clinical Cancer Research

Volumn 17, Issue 18, 2011, Pages 5867-5877

  Kossenkov, Andrew V ^a   Vachani, Anil ^a   Chang, Celia ^a   Nichols, Calen ^a   Billouin, Shere ^a   Horng, Wenhwai ^a   Rom, William N ^b   Albelda, Steven M ^a   Showe, Michael K ^a   Showe, Louise C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CERAMIDE KINASE; CYTOCHROME P450; CYTOCHROME P450 2R1; DEATH RECEPTOR; GENE PRODUCT; MESSENGER RNA; MICRORNA; MITOCHONDRIAL 3 OXOACYL COENZYME A THIOLASE; MITOCHONDRIAL DEOXYGUANOSINE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; PROTEIN BAD; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE 3; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR ELK 4; TRANSCRIPTION FACTOR SPI 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BAD GENE; BENIGN TUMOR; BINDING SITE; BONE MARROW CELL; CERAMIDE KINASE GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOCHROME P450 2R1 GENE; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LUNG NODULE; LUNG NON SMALL CELL CANCER; LYMPHOID CELL; MALE; MICROARRAY ANALYSIS; MITOCHONDRIAL 3 OXOACYL COENZYME A THIOLASE GENE; MITOCHONDRIAL DEOXYGUANOSINE KINASE GENE; MITOCHONDRIAL GENE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; SPHINGOMYELIN PHOSPHODIESTERASE 3 GENE; SPHINGOSINE 1 PHOSPHATE RECEPTOR 5 GENE; T LYMPHOCYTE; UPREGULATION;

AGED; AGED, 80 AND OVER; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MICRORNAS; MIDDLE AGED; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 80052862332     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-0737     Document Type: Article

References (49)

1. ACS. Cancer facts and figures 2010. Atlanta: American Cancer Society; 2010.
2. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-9.
3. Hirschowitz EA, Yannelli JR. Immunotherapy for lung cancer. Proc Am Thorac Soc 2009;6:224-32.
4. Pardoll D. Does the immune system see tumors as foreign or self? Annu Rev Immunol 2003;21:807-39.
5. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263-74. (Pubitemid 40488632)
6. Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001;60:433-41.
7. Novellino L, Castelli C, Parmiani G. A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol Immunother 2005;54:187-207.
8. Raez LE, Fein S, Podack ER. Lung cancer immunotherapy. Clin Med Res 2005;3:221-8.
9. Showe MK, Vachani A, Kossenkov AV, Yousef M, Nichols C, Nikonova EV, et al. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res 2009;69:9202-10.
10. Storey JD, Tibshirani R. Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 2003;224:149-57.
11. Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Machine Learning 2002;46:389-422. (Pubitemid 34129977)
12. Jurman G, Merler S, Barla A, Paoli S, Galea A, Furlanello C. Algebraic stability indicators for ranked lists in molecular profiling. Bioinformatics 2008;24:258-64.
13. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 2006;7:277-300. (Pubitemid 44627931)
14. Single RM, Martin MP, Meyer D, Gao X, Carrington M. Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics 2008;60:711-25.
15. Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cellular Signalling 2008;20:1010-8.
16. Venable ME, Lee JY, Smyth MJ, Bielawska A, Obeid LM. Role of ceramide in cellular senescence. J Biol Chem 1995;270:30701-8. (Pubitemid 26005136)
17. Pozo D, Vales-Gomez M, Mavaddat N, Williamson SC, Chisholm SE, Reyburn H. CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase. J Immunol 2006;176:2397-406. (Pubitemid 43201689)
18. Moreno M, Molling JW, von Mensdorff-Pouilly S, Verheijen RH, von Blomberg BM, van den Eertwegh AJ, et al. In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells. Clin Immunol 2008;129:145-54.
19. Schmieg J, Yang G, Franck RW, Van Rooijen N, Tsuji M. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci U S A 2005;102:1127-32. (Pubitemid 40170737)
20. Suzuki E, Handa K, Toledo MS, Hakomori S. Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert. Proc Natl Acad Sci U S A 2004;101:14788-93. (Pubitemid 39410753)
21. Huynh H, Nguyen TT, Chan E, Tran E. Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation. Int J Oncol 2003;23:821-9.
22. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, et al. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 1995;14:951-62.
23. Boros J, Donaldson I, O'Donnell A, Odrowaz Z, Zeef L, Lupien M, et al. Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res 2009;19:1963-73.
24. Qin H, Chan MW, Liyanarachchi S, Balch C, Potter D, Souriraj IJ, et al. An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst Biol 2009;3:73.
25. Zakrzewska A, Cui C, Stockhammer OW, Benard EL, Spaink HP, Meijer AH. Macrophage-specific gene functions in Spi1-directed innate immunity. Blood 2010;116:e1-11.
26. Kubosaki A, Lindgren G, Tagami M, Simon C, Tomaru Y, Miura H, et al. The combination of gene perturbation assay and ChIP-chip reveals functional direct target genes for IRF8 in THP-1 cells. Mol Immunol 2010;47:2295-302.
27. Dennis G, Sherman B, Hosack D. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 2003;4:P3.
28. Jacques C, Fontaine JF, Franc B, Mirebeau-Prunier D, Triau S, Savagner F, et al. Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours. Br J Cancer 2009;101:132-8.
29. Boros J, Donaldson IJ, O'Donnell A, Odrowaz ZA, Zeef L, Lupien M, et al. Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res 2009;19:1963-73.
30. Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, Martin F, et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun 2005;6:319-31. (Pubitemid 40903405)
31. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005;5:472-84. (Pubitemid 40835035)
32. Chen H-F, Jeung E-B, Stephenson M, Leung PCK. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor {gamma}-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab 1999;84:743-50. (Pubitemid 29075715)
33. Dixit VD, Yang H, Udhayakumar V, Sridaran R. Gonadotropin-releasing hormone alters the T helper cytokine balance in the pregnant rat. Biol Reprod 2003;68:2215-21. (Pubitemid 36687014)
34. Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 2006;298:225-57.
35. Gollamudi M, Nethery D, Liu J, Kern JA. Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines. Lung Cancer 2004;43:135-43. (Pubitemid 38114741)
36. Liu J, Kern JA. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. Am J Respir Cell Mol Biol 2002;27:306-13. (Pubitemid 34979288)
37. Mukohara T, Kudoh S, Matsuura K, Yamauchi S, Kimura T, Yoshimura N, et al. Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC. Anticancer Res 2004;24:11-7. (Pubitemid 38279683)
38. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, et al. miRNAs in lung cancer-studying complex finger-prints in patient's blood cells by microarray experiments. BMC Cancer 2009;9:353.
39. Thomas M, Lieberman J, Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol 2010;17:1169-74.
40. Lee J, Hayashi M, Lo JF, Fearns C, Chu WM, Luo Y, et al. Nuclear factor kappaB (NF-kappaB) activation primes cells to a pro-inflammatory polarized response to a toll-like receptor 7 (TLR7) agonist. Biochem J 2009;421:301-10.
41. Wang T, Lafuse WP, Zwilling BS. NFkappaB and Sp1 elements are necessary for maximal transcription of toll-like receptor 2 induced by Mycobacterium avium. J Immunol 2001;167:6924-32. (Pubitemid 33144186)
42. Basu S, Fenton MJ. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 2004;286:L887-92.
43. Ehlers M, Ravetch JV. Opposing effects of toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol 2007;28:74-9. (Pubitemid 46176735)
44. Bharti A, Ma PC, Salgia R. Biomarker discovery in lung cancer-promises and challenges of clinical proteomics. Mass Spectrom Rev 2007;26:451-66. (Pubitemid 46750379)
45. Meyerson M, Carbone D. Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy. J Clin Oncol 2005;23:3219-26. (Pubitemid 46211346)
46. Ostroff RM, Bigbee WL, Franklin W, Gold L, Mehan M, Miller YE, et al. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 2010;5:e15003.
47. Redente EF, Dwyer-Nield LD, Merrick DT, Raina K, Agarwal R, Pao W, et al. Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. Am J Pathol 2010;176:2972-85.
48. Redente EF, Higgins DM, Dwyer-Nield LD, Orme IM, Gonzalez-Juarrero M, Malkinson AM. Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol 2010;88:159-68.
49. Redente EF, Orlicky DJ, Bouchard RJ, Malkinson AM. Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice. Am J Pathol 2007;170:693-708. (Pubitemid 47339405)